Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Abbott Laboratories (ABT) trades at a EV/Sales of 4.5×. Over the past ten years it has ranged from 2.6× (September 2015) to 6.9× (February 2021); the current reading is higher than 43% of that period. That is above the Medical Devices industry median of 2.2× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 5.0× 3.56%
FY2024 4.8× (2.25%)
FY2023 5.0× 8.75%
FY2022 4.6× (23.89%)
FY2021 6.0× 0.71%
FY2020 5.9× 13.20%
FY2019 5.2× 12.62%
FY2018 4.7× 5.96%
FY2017 4.4× 53.84%
FY2016 2.9× (12.89%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 4.0× (12.88%)
Mar 2026 4.6× (9.07%)
Dec 2025 5.0× (7.91%)
Sep 2025 5.4× (3.59%)
42 more quarters

Against its own ten years

Low 2.6× High 6.9×
Ten-year median 4.7×
Current reading's percentile 38

EV/Sales against peers

Company EV/Sales
PHG Koninklijke Philips N.V. compare 1.4×
GEHC GE HealthCare Technologies Inc. compare 1.9×
BSX Boston Scientific Corporation compare 3.7×
MDT Medtronic PLC compare 3.7×
STE STERIS plc compare 3.8×
ABT Abbott Laboratories 4.5×
SYK Stryker Corporation compare 4.8×
DXCM DexCom, Inc. compare 6.6×
EW Edwards Lifesciences Corporation compare 7.2×
Medical Devices industry median 2.2×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ABT